Prostate Cancer - Results from #120

Radical Prostatectomy in Multimodal Setting: Current Role of Neoadjuvant and Adjuvant Hormonal or Chemotherapy-Based Treatments. February 27, 2025

Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settings. February 26, 2025

Bridging the Gap: Enhancing Prostate Cancer Survivorship and Advocacy Among Ethnically Diverse Black Men Through Community Town Halls. February 26, 2025

Assessing the Impact of Transition and Peripheral Zone PSA Densities Over Whole-Gland PSA Density for Prostate Cancer Detection on Multiparametric MRI. February 26, 2025

A multi-perspective study assessing Black and African American participation barriers in prostate cancer clinical trials. February 26, 2025

Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer During Serial Therapy. February 26, 2025

Radionuclide therapy in 2025: nuclear medicine options in the treatment of metastatic castration-resistant prostate cancer. February 25, 2025

Association between the use of proton pump inhibitors and serum PSA levels in the general U.S. population. February 25, 2025

A free method for patient-specific 3D-VR anatomical modeling for presurgical planning using DICOM images and open-source software. February 25, 2025

The Landscape of Supportive Care Needs Among Prostate Cancer Patients in New Zealand: A Cross-Ethnic Analysis. February 25, 2025

Impact of positive surgical margin location after radical prostatectomy: a network meta-analysis. February 25, 2025

Incorporating indirect MRI information in a CT-based deep learning model for prostate auto-segmentation. February 25, 2025

Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancer. February 24, 2025

Inhibition of PIM kinase in tumor-associated macrophages suppresses inflammasome activation and sensitizes prostate cancer to immunotherapy. February 24, 2025

Defining The Role for Hormone Therapy in Biochemically Recurrent Prostate Cancer: What Counts as a Win for Patients? February 24, 2025

Validation of a digital pathology-based multimodal artificial intelligence biomarker in a prospective, real-world prostate cancer cohort treated with prostatectomy. February 24, 2025

Stereotactic body radiotherapy (SBRT) as a treatment for localized prostate cancer: a retrospective analysis. February 24, 2025

Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials. February 24, 2025

MRI in Prostate Cancer Screening: A Review and Recommendations, From the AJR Special Series on Screening. February 21, 2025

Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719). February 21, 2025

Page 7 of 1467